This is evident by the release of cytokines and the upregulation of co-stimulatory cell-surface markers upon monocyte activation by CSPG4 IgE in vitro, and tumor infiltration of macrophages and immune signaling pathway activation in tumors of CSPG4 IgE-treated mice. Here, CSPG4 is linked to neoplasm.